531 related articles for article (PubMed ID: 27931616)
1. MicroRNAs in Cardiovascular Disease.
Barwari T; Joshi A; Mayr M
J Am Coll Cardiol; 2016 Dec; 68(23):2577-2584. PubMed ID: 27931616
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs as Candidate Drug Targets for Cardiovascular Diseases.
Hang P; Guo J; Sun C; Du Z
Curr Drug Targets; 2017; 18(4):463-472. PubMed ID: 26926467
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs in cardiovascular disease: an introduction for clinicians.
Romaine SP; Tomaszewski M; Condorelli G; Samani NJ
Heart; 2015 Jun; 101(12):921-8. PubMed ID: 25814653
[TBL] [Abstract][Full Text] [Related]
4. microRNAs in Cardiovascular Disease: Small Molecules but Big Roles.
Yan B; Wang H; Tan Y; Fu W
Curr Top Med Chem; 2019; 19(21):1918-1947. PubMed ID: 31393249
[TBL] [Abstract][Full Text] [Related]
5. [The role of micro-ribonucleic acid in disease development].
Widjaya B; Seidelin JB; Olsen J; Nielsen OH
Ugeskr Laeger; 2009 Nov; 171(47):3441-4. PubMed ID: 19925731
[TBL] [Abstract][Full Text] [Related]
6. Uncovering novel landscape of cardiovascular diseases and therapeutic targets for cardioprotection via long noncoding RNA-miRNA-mRNA axes.
He L; Chen Y; Hao S; Qian J
Epigenomics; 2018 May; 10(5):661-671. PubMed ID: 29692219
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-based therapeutic approaches in the cardiovascular system.
Fiedler J; Gupta SK; Thum T
Cardiovasc Ther; 2012 Feb; 30(1):e9-e15. PubMed ID: 20946325
[TBL] [Abstract][Full Text] [Related]
8. The beagle dog MicroRNA tissue atlas: identifying translatable biomarkers of organ toxicity.
Koenig EM; Fisher C; Bernard H; Wolenski FS; Gerrein J; Carsillo M; Gallacher M; Tse A; Peters R; Smith A; Meehan A; Tirrell S; Kirby P
BMC Genomics; 2016 Aug; 17():649. PubMed ID: 27535741
[TBL] [Abstract][Full Text] [Related]
9. Identification of cardiovascular microRNA targetomes.
Fiedler J; Gupta SK; Thum T
J Mol Cell Cardiol; 2011 Nov; 51(5):674-81. PubMed ID: 21888912
[TBL] [Abstract][Full Text] [Related]
10. miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart.
Bernardo BC; Ooi JY; Lin RC; McMullen JR
Future Med Chem; 2015; 7(13):1771-92. PubMed ID: 26399457
[TBL] [Abstract][Full Text] [Related]
11. The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.
Duarte FV; Palmeira CM; Rolo AP
Adv Exp Med Biol; 2015; 888():123-54. PubMed ID: 26663182
[TBL] [Abstract][Full Text] [Related]
12. Trials and Tribulations of MicroRNA Therapeutics.
Seyhan AA
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338746
[TBL] [Abstract][Full Text] [Related]
13. The Role of microRNA in the Development, Diagnosis, and Treatment of Cardiovascular Disease: Recent Developments.
Wronska A
J Pharmacol Exp Ther; 2023 Jan; 384(1):123-132. PubMed ID: 35779862
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA Signature and Cardiovascular Dysfunction.
Arunachalam G; Upadhyay R; Ding H; Triggle CR
J Cardiovasc Pharmacol; 2015 May; 65(5):419-29. PubMed ID: 25384197
[TBL] [Abstract][Full Text] [Related]
15. Small Molecules with Big Impacts on Cardiovascular Diseases.
Mirzadeh Azad F; Arabian M; Maleki M; Malakootian M
Biochem Genet; 2020 Jun; 58(3):359-383. PubMed ID: 31997044
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs in the onset and development of cardiovascular disease.
Vickers KC; Rye KA; Tabet F
Clin Sci (Lond); 2014 Feb; 126(3):183-94. PubMed ID: 24102098
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs: a novel class of potential therapeutic targets for cardiovascular diseases.
Pan ZW; Lu YJ; Yang BF
Acta Pharmacol Sin; 2010 Jan; 31(1):1-9. PubMed ID: 19966833
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs in Ischemic Heart Disease: From Pathophysiology to Potential Clinical Applications.
Lima J; Batty JA; Sinclair H; Kunadian V
Cardiol Rev; 2017; 25(3):117-125. PubMed ID: 27465537
[TBL] [Abstract][Full Text] [Related]
19. HDL and microRNA therapeutics in cardiovascular disease.
Michell DL; Vickers KC
Pharmacol Ther; 2016 Dec; 168():43-52. PubMed ID: 27595929
[TBL] [Abstract][Full Text] [Related]
20. Unlocking the door to new therapies in cardiovascular disease: microRNAs hold the key.
Nguyen MA; Karunakaran D; Rayner KJ
Curr Cardiol Rep; 2014 Nov; 16(11):539. PubMed ID: 25303893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
